Identigene sells in-home DNA paternity test collection kits, while DNA Diagnostics conducts DNA testing for various applications, such as paternity and forensics.
Thermo Fisher said the deal strengthens its portfolio for stem cell research, and it will fold MTI-GlobalStem into its life sciences solutions segment.
The company purchased Tute in a stock-based transaction that closed last month.
The diagnostics provider said it has paid $250,000 for assets comprised of promissory notes, Series A and Series B stock, and intellectual property.
The deal marks the first software-related acquisition for Agilent since the firm acquired Cartagenia last year.
The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
The company said FEI's technology will complement its mass spectrometry business, particularly in its work on structural proteins and biopharmaceuticals.
The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.
The genomics company is set to acquire LifebankUSA, which was founded by HLI's own co-founder, from Celgene's Cellular Therapeutics subsidiary.
The UK diagnostics company is selling the subsidiary back to its two cofounders less than two years after buying it.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.